Cargando…

Possible metabolic interaction between docetaxel and ifosfamide

Detalles Bibliográficos
Autor principal:	Ando, Y
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363263/ https://www.ncbi.nlm.nih.gov/pubmed/10646911 http://dx.doi.org/10.1054/bjoc.1999.0949

Ejemplares similares

Phase I study of docetaxel plus ifosfamide in patients with advanced cancer
por: Marx, G, et al.
Publicado: (2002)

Phase 1 study on docetaxel and ifosfamide in patients with advanced solid tumours
Publicado: (1998)

Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.
por: Pronk, L. C., et al.
Publicado: (1998)

The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)

Phase I–II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer
por: Kosmas, C, et al.
Publicado: (2003)

Docetaxel–induced syndrome of inappropriate antidiuretic hormone secretion
por: Chaudhuri, Tamojit, et al.
Publicado: (2013)

Trastuzumab–Docetaxel Combination Chemotherapy Induced Severe Onychopathy
por: Sonthalia, Sidharth, et al.
Publicado: (2017)

Carbamazepine and Multiple Myeloma: Possible Interaction
por: Günaldı, Meral, et al.
Publicado: (2013)

Metabolism of ifosfamide during a 3 day infusion.
por: Hartley, J. M., et al.
Publicado: (1994)

The growing pains of ifosfamide
por: Sprangers, Ben, et al.
Publicado: (2020)

Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab
por: Hata, Akito, et al.
Publicado: (2018)

Myalgia-arthralgia syndrome induced by docetaxel in oncology: the wolf disguised as a sheep
por: Cidon, Esther Una
Publicado: (2018)

Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis
por: Xu, Jian, et al.
Publicado: (2019)

Ifosfamide nephrotoxicity in adult patients
por: Ensergueix, Gaël, et al.
Publicado: (2019)

Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy
por: Andres, R, et al.
Publicado: (2002)

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value
por: Garantziotis, S
Publicado: (2011)

Reply: Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value
por: Michlmayr, A, et al.
Publicado: (2011)

Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
por: Van der Speeten, Kurt, et al.
Publicado: (2011)

Ifosfamide-Induced Malignancy of Ureter and Bladder
por: Sannu, Aparna, et al.
Publicado: (2017)

Partial Fanconi Syndrome Induced by Ifosfamide
por: Das, Sulagna, et al.
Publicado: (2019)

Ifosfamide as a Cause of Fanconi Syndrome
por: Martinez, Daniel, et al.
Publicado: (2022)

Hypoxia and HIF activation as a possible link between sepsis and thrombosis
por: Evans, Colin E.
Publicado: (2019)

Possible link between anosmia and COVID-19: sniffing out the truth
por: Marinosci, Annalisa, et al.
Publicado: (2020)

Possible Associations Between Alopecia Areata and COVID-19 Vaccination and Infection
por: Birkett, Liam, et al.
Publicado: (2022)

SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
por: Ma, Yuxiang, et al.
Publicado: (2021)

“PiMa sign”: A possible correlation between dermographism and pityriasis versicolor?
por: Martora, Fabrizio, et al.
Publicado: (2022)

Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306
por: Tanaka, Kazuhiro, et al.
Publicado: (2022)

The influence of ifosfamide scheduling on acute nephrotoxicity in children.
por: English, M. W., et al.
Publicado: (1997)

Effect of Glutathione Depletion on Ifosfamide Nephrotoxicity in Rats
por: Garimella-Krovi, Sudha, et al.
Publicado: (2008)

Ifosfamide-induced Fanconi syndrome with diabetes insipidus
por: Leem, Ah Young, et al.
Publicado: (2014)

Karyomegalic interstitial nephropathy following ifosfamide therapy
por: Jayasurya, R., et al.
Publicado: (2016)

Reversible Encepahlopathy Induced by Ifosfamide with Brain Imaging
por: Ali Mohamed, Daoud, et al.
Publicado: (2021)

Possible Transmission of mcr-1–Harboring Escherichia coli between Companion Animals and Human
por: Zhang, Xue-Fei, et al.
Publicado: (2016)

Susceptibility of Fibromatosis Cells in Short-Term Culture to Ifosfamide: A Possible Experimental Treatment in Clinically Aggressive Cases
por: Verrill, Mark W., et al.
Publicado: (1999)

Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer
por: Willits, I, et al.
Publicado: (2005)

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
por: Requilé, Annelies, et al.
Publicado: (2017)

Analysis of Continuous Blood Glucose Data in People with Type 1 Diabetes (T1DM) After COVID-19 Vaccination Indicates a Possible Link Between the Immune and the Metabolic Response
por: Heald, Adrian H., et al.
Publicado: (2021)

Comparative seasonalities of influenza A, B and ‘common cold’ coronaviruses – setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions
por: Liu, Yang, et al.
Publicado: (2020)

Interaction between tacrolimus and clindamycin
por: Jouret, François, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vpdklbhef4nkp73lfj9529qsvf